Clinical Trials Browser

Phase NA × apatinib × Other solid neoplasm × Clear all

NCT05380986 2022-05-19

Camrelizumab Combined With Apatinib Mesylate

Phase NA Unknown

Other solid neoplasm

Solid Tumor